Swapnil Shinkar | Formulation Science | Best Researcher Award

Swapnil Shinkar | Formulation Science | Best Researcher Award

Mr Swapnil Shinkar, National Institute of Technology Raipur, India

Mr. Swapnil Shinkar is a dedicated statistician and academician pursuing his Ph.D. in Statistics from NIT Raipur. With extensive teaching and research experience, he has served as a Statistician Cum Assistant Professor in various medical institutions, currently at Shri Shankaracharya Institute of Medical Sciences, Bhilai. Proficient in statistical software like SPSS, R, and MINITAB, he specializes in data analysis and research methodology. His work includes publications on queuing models and simulation approaches. Certified in Six Sigma Green Belt and Data Science, he actively contributes to statistical research and medical education. πŸ“šπŸ“ˆ

Publication Profile

orcid

Education

Mr. Swapnil Shinkar πŸŽ“ is currently pursuing a Ph.D. in Statistics from the National Institute of Technology, Raipur, with his thesis submission expected after August 2025. He has already earned a Ph.D. in Statistics from Rashtrasant Tukadoji Maharaj Nagpur University (Notification: January 2024). He completed his M.Sc. in Statistics (2010-2012) and B.Sc. in Statistics (2005-2008) with commendable scores. His academic journey began at Nashik Board, where he completed his H.S.C. and S.S.C. πŸ“Š Proficient in statistical software, he is skilled in SPSS, MINITAB, SyStat, R Programming, and MS Excel, making him a data-driven analytical expert. πŸ“ˆ

Experience

Mr. Swapnil Shinkar πŸŽ“ is a seasoned statistician and academician with extensive experience in teaching and research. He is currently serving as a Statistician Cum Assistant Professor in the Department of Community Medicine at Shri Shankaracharya Institute of Medical Sciences, Bhilai (since July 2024). Previously, he held similar roles at Vedantaa Institute of Medical Sciences, Symbiosis Medical College for Women, and Pt. J. N. M. Medical College, contributing significantly to medical research and education. His journey also includes a Junior Research Fellowship (SERB) at RTM Nagpur University and experience as a Contributory Lecturer, shaping future researchers. πŸ“ŠπŸ“š

Administrative Experience

Mr. Swapnil Shinkar πŸŽ“ has extensive administrative experience in the medical and academic sectors. He served as a Regulatory Officer at Vedantaa Institute of Medical Sciences, Palghar, from March 2023 to June 2024, ensuring compliance and governance. Previously, he held the role of Nodal Officer at the same institute from July 2017 to February 2019, managing key responsibilities. Additionally, he was In-charge of the Medical Record Department at Shri Shankaracharya Institute of Medical Sciences, Bhilai, from September 2016 to June 2017. His leadership and organizational skills have significantly contributed to institutional operations. πŸ₯πŸ“Š

Research Guidance

Mr. Swapnil Shinkar πŸŽ“ has extensive experience in research guidance, particularly in statistical analysis. In the non-medical domain, he has mentored over 30 Ph.D. candidates, providing expert statistical insights. In the medical field, he has guided 15 undergraduate project groups in research planning and statistical analysis. Additionally, he supports more than 100 postgraduate medical candidates annually, assisting them in data analysis and research methodology. His expertise in statistics plays a crucial role in shaping high-quality research across multiple disciplines, making him a sought-after mentor and advisor in academic and medical research. πŸ“ŠπŸ“š

Research Focus

Dr. Swapnil Shinkar’s research primarily focuses on public health epidemiology πŸ₯, community medicine 🌍, and infectious disease surveillance 🦠. His work spans hypertension prevalence among tribal populations, HIV risk factors, oral cancer screening, and COVID-19 studies. Additionally, he has contributed to biostatistics education, tuberculosis screening, and child development programs. His expertise extends to healthcare accessibility πŸš‘, disease prevention πŸ›‘, and health policy evaluation πŸ“Š. Through cross-sectional and longitudinal studies, he provides critical insights into health disparities and medical education πŸ“–. His multidisciplinary approach helps bridge the gap between epidemiology, healthcare interventions, and public health policies.

Publication Top Notes

Zeynep Kalaycıoğlu | Pharmaceutical Chemistry | Best Researcher Award

Zeynep Kalaycıoğlu | Pharmaceutical Chemistry | Best Researcher Award

Assoc. Prof. Dr Zeynep Kalaycıoğlu, Istanbul Technical University, Turkey

Assoc. Prof. Dr. Zeynep KalaycΔ±oğlu is a distinguished researcher and lecturer at Istanbul Technical University πŸ›οΈ, specializing in analytical chemistry πŸ§ͺ. Her expertise spans metal/metal oxide nanoparticle synthesis, drug-protein interactions, and biopolymeric composite films for food packaging and wound dressing 🌱. With over 30 high-impact publications πŸ“„, two book chapters πŸ“š, and multiple research projects, she has significantly contributed to multidisciplinary collaborations in materials science, biochemistry, and pharmaceutical sciences πŸ†. Currently, she leads a funded project on green synthesis of bioactive nanoparticles from olive mill wastewater 🌿, promoting sustainability in scientific innovation. πŸš€

Publication Profile

Scopus

Professional Background

Assoc. Prof. Dr. Zeynep KalaycΔ±oğlu is an academic researcher and lecturer at Istanbul Technical University, specializing in analytical chemistry πŸ”¬. Her Ph.D. focused on isolating and characterizing bioactive compounds from natural products 🌿, developing advanced analytical techniques, and exploring biopolymer applications. With extensive experience in teaching analytical chemistry labs 🏫, she has guided students through complex experimental techniques. Her research interests span metal/metal oxide nanoparticle synthesis βš›οΈ, drug-protein interactions πŸ’Š, and biopolymeric composite films. Dr. KalaycΔ±oğlu collaborates with multidisciplinary teams across materials science, biochemistry, and pharmaceutical sciences, contributing to cutting-edge advancements in her field πŸ”.

Professional Memberships

Assoc. Prof. Dr. Zeynep KalaycΔ±oğlu is a dedicated member of the Turkish Chemical Society βš—οΈ and an expert in analytical chemistry πŸ”¬. Her research focuses on metal/metal oxide nanoparticle synthesis βš›οΈ, drug-protein interactions πŸ’Š, and biopolymeric composite films for food packaging πŸ₯« and wound dressing 🩹. She also specializes in capillary electrophoresis, statistical analysis πŸ“Š, food analysis 🍎, and water remediation πŸ’§. Additionally, her work involves molecular docking 🧬 to explore chemical interactions at the molecular level. Through her multidisciplinary research, Dr. KalaycΔ±oğlu continues to contribute innovative solutions to chemistry, materials science, and pharmaceutical applications.

Academic Research

Assoc. Prof. Dr. Zeynep KalaycΔ±oğlu actively shares her research through various academic platforms 🌐. Her profiles on Google Scholar πŸ“š, ResearchGate πŸ”¬, and LinkedIn πŸ’Ό showcase her contributions to analytical chemistry and multidisciplinary studies. These platforms highlight her publications, collaborations, and scientific impact. Additionally, she maintains a repository of relevant ID and certification documents πŸ†, ensuring transparency and credibility in her academic journey. By engaging with global researchers and institutions, Dr. KalaycΔ±oğlu continues to advance knowledge in nanoparticle synthesis, drug-protein interactions, and biopolymeric applications, making significant contributions to science and technology.

Awards

Assoc. Prof. Dr. Zeynep KalaycΔ±oğlu is honored to be considered for prestigious scientific awards πŸ†. With her extensive contributions to analytical chemistry, nanoparticle synthesis βš›οΈ, and biopolymeric applications 🌿, she aligns with categories such as the Distinguished Scientist Award, Outstanding Scientist Award, and Excellence in Research πŸ”¬. As a dedicated educator and innovator, she also qualifies for the Best Faculty Award πŸŽ“ and Best Innovation Award πŸ’‘. Passionate about advancing science and mentoring future researchers, she seeks recognition that reflects her commitment to groundbreaking discoveries and impactful contributions to multidisciplinary research.

Research Focus

Assoc. Prof. Dr. Zeynep KalaycΔ±oğlu’s research primarily focuses on biophysical chemistry πŸ§ͺ, particularly the interaction of biomolecules 🧬 with pharmaceutical and polymeric compounds. Her work spans protein-ligand binding πŸ”¬, spectroscopic characterization πŸ“Š, and molecular docking analysis πŸ–₯️ to understand biochemical interactions at a molecular level. She also explores nanomaterials βš›οΈ for biomedical applications, including wound healing hydrogels 🩹 and drug delivery systems πŸ’Š. Her expertise in capillary electrophoresis ⚑ further enhances the understanding of biomolecular interactions. Through her interdisciplinary approach, she contributes to advancements in biomedical engineering πŸ₯, materials science πŸ—οΈ, and pharmaceutical research 🌱.

Publication Top Notes

Binding interaction between sodium carboxymethyl cellulose and serum albumin: Insights from multi-spectroscopy methods, rheological characterization and molecular docking analysis

Foam-based antibacterial hydrogel composed of carboxymethyl cellulose/polyvinyl alcohol/cerium oxide nanoparticles for potential wound dressing

Capillary Electrophoresis-Frontal Analysis (CE-FA) and Molecular Docking Studies on the Albumin-Binding Properties of Dopamine and Serotonin

Liangliang Dai | Drug Delivery Systems | Best Researcher Award

Liangliang Dai | Drug Delivery Systems | Best Researcher Award

ProfΒ  Liangliang Dai, Northwestern Polytechnical University, China

Prof. Liangliang Dai Associate Professor & Assistant Dean, Institute of Medical Research, Northwestern Polytechnical University. With a PhD and MD in Biomedical Engineering and Biology from Chongqing University under Prof. Kaiyong Cai, Prof. Dai’s research focuses on nanomaterials, drug delivery systems, nanosystems, tumor immunotherapy, and antimetabolic therapy. He has led multiple national and provincial research projects and published in top journals like Nature Communications and Advanced Functional Materials. His innovative work bridges nanotechnology and cancer therapy, advancing biomedical science. πŸ”¬πŸŒΏ

Publication Profile

orcid

Education Background

Prof. Liangliang Dai holds a Ph.D. in Biomedical Engineering πŸŽ“ from the Ministry of Education College of Bioengineering at Chongqing University, where he conducted advanced research under the mentorship of Prof. Kaiyong Cai. His academic journey also includes an MD in Biology 🧬 from the same institution, further solidifying his expertise in bioengineering and biomedical sciences. Guided by Prof. Cai, his studies focused on cutting-edge innovations in the field. With a strong foundation in interdisciplinary research, Prof. Dai continues to contribute to scientific advancements in biomedical engineering and biology, shaping the future of healthcare and biotechnology πŸ”¬.

Hosted Research Project

Prof. Liangliang Dai has led several prestigious research projects πŸ”¬, contributing significantly to biomedical engineering. He has been awarded funding from the National Natural Science Foundation of China πŸ… for multiple projects (52373157, 52003223) and has received the National Science Foundation for Distinguished Young Scholars of Shaanxi Province (S2025-JC-JQ-0228). Additionally, he has played a key role in the Key R&D Programs of Shaanxi Province (2024SF2-GJHX-26, 2022SF-012) and secured support from the Natural Science Foundation of Shaanxi Province (2019JQ-347) and the Young Talent Fund of University Association for Science and Technology (20200302) 🌍.

Research Contributions

Prof. Liangliang Dai has secured multiple prestigious research grants πŸ…, including funding from the National Natural Science Foundation of China and the Key R&D Program of Shaanxi Province. His research focuses on advanced drug delivery systems πŸ’Š, tumor immunotherapy 🧬, and biomedical nanotechnology πŸ”¬, making significant contributions to the medical research community. These competitive grants reflect his expertise and the high regard for his work in the scientific field. Through pioneering innovations, Prof. Dai continues to push the boundaries of biomedical engineering, striving for breakthroughs that enhance healthcare and therapeutic solutions globally 🌍.

Global RecognitionΒ 

Prof. Liangliang Dai is a globally recognized researcher 🌍, collaborating with renowned scientists to develop innovative therapeutic strategies πŸ”¬. His groundbreaking work in cancer therapy 🧬 and nanomaterial-based drug delivery πŸ’Š is paving the way for more effective medical treatments. Beyond securing prestigious grants and publishing impactful research, his contributions hold practical significance in biomedical applications, transforming healthcare solutions. With a commitment to advancing science, Prof. Dai’s influence continues to grow, driving innovation and shaping the future of medicine through cutting-edge technologies and interdisciplinary collaborations 🀝.

Innovative Research

Prof. Liangliang Dai’s research is highly interdisciplinary πŸ”¬, blending nanotechnology, immunotherapy, and bioengineering to advance medical science. His groundbreaking work on multifunctional metal-organic frameworks πŸ—οΈ, light-activatable antibiosis for infected bone repair 🦴, and tumor microenvironment modulation 🧬 showcases his pioneering role in translational medicine. By enhancing cancer treatment strategies πŸŽ—οΈ and optimizing drug delivery systems πŸ’Š, his studies have a direct impact on healthcare. Through cutting-edge innovations, Prof. Dai is shaping the future of biomedical science, driving transformative solutions that improve patient outcomes and therapeutic effectiveness worldwide 🌍.

Research Focus

Liangliang Dai’s research primarily focuses on nanotechnology and biomedical engineering πŸ§ͺπŸ”¬, with a particular emphasis on nanosystems for drug delivery, tumor therapy, and environmental applications. His work explores nanoparticles, metal-organic frameworks (MOFs), and photo-responsive materials to develop advanced cancer treatments πŸŽ—οΈ, chemodynamic therapy βš›οΈ, immune modulation πŸ›‘οΈ, and antimicrobial strategies 🦠. Dai also investigates water purification πŸ’§ and biofilm control to tackle antibiotic resistance. His research bridges materials science πŸ—οΈ and biomedicine to create multifunctional therapeutic nanosystems, advancing precision medicine 🧬 and environmental health 🌍.

Publication Top Notes

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Dr Hui Xiao,regeneron,United States

Dr. Hui Xiao πŸ§ͺπŸ”¬ is a distinguished scientist specializing in biochemistry, structural biology, and mass spectrometry. With a strong focus on microtubule dynamics, protein interactions, and drug mechanisms, he has made significant contributions to understanding cellular processes. As a co-first author and lead researcher, his work has been published in esteemed journals like J. Mol. Biol., Biochemistry, and J. Biol. Chem.. His expertise spans hydrogen-deuterium exchange, proteomics, and molecular stabilization studies. Dr. Xiao’s research has advanced drug discovery, particularly in cancer therapeutics and protein biochemistry. πŸ“šπŸ” His innovative approaches continue to impact biomedical sciences globally. 🌍✨

Publication Profile

Scopus

Education

Dr. Hui Xiao πŸŽ“ holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst (2005) and a degree in Applied Chemistry from Peking University, China (1992). Currently serving as an Associate Director at Regeneron Pharmaceuticals 🏒, he specializes in protein characterization using mass spectrometry. With over a decade at Regeneron, he has progressed through roles as a Senior Staff Scientist and Staff Scientist. Previously, he held academic positions at Albert Einstein College of Medicine 🧬, advancing from Instructor to Research Associate Professor. His expertise spans analytical chemistry, protein analysis, and therapeutic protein research, making significant contributions to biomedical science. πŸ”¬

Professional Impact

Dr. Hui Xiao πŸŽ“ is a distinguished scientist with over 20 years of experience in academia and the biotechnology industry. Currently, he serves as an Associate Director of Analytical Chemistry at Regeneron Pharmaceuticals 🏒, a leading biotech company. His expertise lies in mass spectrometry applications for protein characterization πŸ”¬, contributing to advancements in therapeutic development. Before joining Regeneron, Dr. Xiao held esteemed faculty positions at Albert Einstein College of Medicine 🧬, progressing from Instructor to Research Associate Professor. His extensive research and leadership have played a crucial role in bridging analytical chemistry with biopharmaceutical innovation, impacting drug discovery and development. πŸš€

Scientific Contributions

Dr. Hui Xiao πŸŽ“ is a leading expert in protein-ligand interactions, structural proteomics, and therapeutic protein analysis πŸ”¬. His pioneering work includes the application of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for epitope mapping 🧩 and microtubule stabilization research. With a deep focus on drug characterization and regulatory sciences, his contributions have significantly advanced biopharmaceutical development πŸ’Š. His expertise in mass spectrometry-driven protein analysis has helped enhance the understanding of molecular mechanisms, improving therapeutic strategies. Through innovation and research, Dr. Xiao continues to play a vital role in shaping the future of biopharmaceutical science and drug discovery. πŸš€

Potential Considerations

Dr. Hui Xiao πŸŽ“ is a renowned expert in analytical and protein chemistry, with groundbreaking work in epitope mapping and protein characterization πŸ”¬. While his contributions significantly impact drug development, the Pharmaceutical Innovation Achievement Award πŸ† may prioritize direct advancements in drug discovery and novel pharmaceutical interventions πŸ’Š. His research has important regulatory and therapeutic implications, but highlighting specific drug innovations or regulatory breakthroughs he has led would further strengthen his case. By showcasing his role in pioneering pharmaceutical advancements, Dr. Xiao’s influence in shaping modern biopharmaceutical science can be fully recognized and appreciated. πŸš€

Research Focus

Dr. Hui Xiao’s research primarily focuses on analytical chemistry πŸ§ͺ, particularly in the quantitative analysis of biomolecules 🧬 using advanced mass spectrometry techniques βš–οΈ. His work involves CRISPR sgRNA modification analysis πŸ§¬πŸ”¬ and the development of LC-MS-based assays for biological therapeutics πŸ’Š. He specializes in phosphorothioate isomer detection πŸ”„ and liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) πŸ“Š for precise biomolecular quantification. His contributions are crucial in drug discovery πŸ₯, gene editing 🧬, and biopharmaceutical development πŸ’‰. His expertise bridges biotechnology πŸ”¬ and analytical methodologies πŸ“ˆ, advancing innovations in therapeutic monitoring and molecular diagnostics πŸ₯.

Publication Top Notes

Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)

Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum